www.zephyrai.bioHealthcare / Other HealthcareFounded: 2020
Zephyr AI is a healthcare technology company that aims to develop new precision medicine treatments in oncology and cardiometabolic diseases. The company uses its platform’s AI capabilities and data analytics to look at vast amounts of healthcare information. With this, the company has a mission to serve patients through tailored treatment plans, potential new drug discoveries, repositioning existing drugs for new use cases, and clinical decision support that seeks to enable doctors to make informed decisions. Zephyr AI was founded by Grant L. Verstandig and Jeff Sherman in 2020 and is headquartered in Fairfax, VA.
View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Zephyr AI.
Become part of the Secondary Marketplace, catering to both individual and institutional investors.